Pfizer Urges 3rd Circ. To Uphold Alzheimer Drug Ruling
Pfizer Inc. on Friday urged the Third Circuit not to revive a class action alleging it misled shareholders about the potential of an Alzheimer's drug that ultimately failed, arguing the suit...To view the full article, register now.
Already a subscriber? Click here to view full article